Alpha GPC

A 2012 study by Goliier in CNS and Neurological Disorders Drug Targets compared aniracetam alone vs aniracetam + Alpha GPC in 140 patients with age-related cognitive decline. Aniracetam alone produced 34% cognitive improvement after 12 weeks; aniracetam plus Alpha GPC produced 67% improvement — nearly double. Both are oral compounds.

A 2011 study by Gaspari in CNS Drug Reviews showed Alpha GPC at 600mg daily increased cerebral acetylcholine levels by 40%. Alpha GPC is 40% choline by weight and crosses the blood-brain barrier efficiently. It provides choline in a phosphorylated form neurons can immediately use for both acetylcholine synthesis and membrane repair.

The complete anti-anxiety/brain-fog protocol: (1) Fix foundational deficiencies first — magnesium glycinate 400-600mg daily (evening), omega-3 DHA/EPA, vitamin D3 5,000-10,000 IU daily (target blood levels 40-60). These alone address ~60% of anxiety/brain fog. (2) Then add aniracetam + Alpha GPC (600mg daily for Alpha GPC) as 'a precise laser tool' on top of the foundation. Aniracetam dosage not stated due to platform restrictions.

Using aniracetam without Alpha GPC is compared to running an engine at high RPMs with no oil. Aniracetam increases metabolic demand and AMPA receptor signaling (more calcium influx, greater ATP consumption), requiring more acetylcholine. Without the choline substrate from Alpha GPC, this leads to increased neuroinflammation, accelerated membrane degradation, and a net negative effect.